IP Library Granted Patent US 10,004,779
Granted Patent B2
US 10,004,779 · App. 14/962,592 · Granted Jun 26, 2018

Elastin protective polyphenolics and methods of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,779
App. No.
14/962,592
Granted
Jun 26, 2018
Kind
B2
Abstract

Dermal fibroblasts permanently loose their ability to synthesize elastin, the major component of elastic fibers, shortly after puberty. This progressive loss of elastic fibers cannot be replaced, resulting in the physical signs of aging. The present invention provides methods and compositions containing the polyphenols ellagic acid and/or tannic acid for protection against degradation of cutaneous elastic fibers by the elastolytic enzymes. The use of ellagic acid and/or tannic acid increased the overall deposition of elastic fibers in healthy and damaged skin cells. The protection of both intra-tropoelastin and extra-cellular mature elastic fibers from proteolytic enzymes by ellagic acid and tannic acid caused an increase in the net deposition of elastic fibers. Therefore, embodiments of the present invention provide methods and composition for the treatment of skin and prevention and treatment of degradation of dermal elastic fibers.

Claims (11)

1. A topical composition comprising an effective amount of a polyphenolic compound selected from tannic acid, ellagic acid, and combinations thereof, and a synthetic peptide having the sequence Val-Gly-Val-Ala-Pro-Gly (SEQ ID NO: 19), wherein the effective amount of the polyphenolic compound ranges from about 1 microgram to about 10 micrograms.

2. The composition of claim 1 , wherein the effective amount of the polyphenolic compound is about 1 microgram.

3. A method for protecting elastin fibers from degradation comprising topically administering to the skin in need thereof a composition comprising an effective amount of a polyphenolic compound selected from tannic acid, ellagic acid, and combinations thereof, and a peptide having the sequence Val-Gly-Val-Ala-Pro-Gly (SEQ ID NO: 19), wherein the effective amount of the polyphenolic compound ranges from about 1 microgram to about 10 micrograms.

4. The method of claim 3 , further comprising administering a stimulator of elastogenesis selected from elastin-derived peptides, plant-derived peptides, bovine-derived peptides, manganese, iron, copper, and any combination thereof.

5. The method of claim 4 , wherein the composition and the stimulator of elastogenesis are administered simultaneously or sequentially.

6. A method for protecting dermal tissue from damage by irradiation comprising topically administering to the skin in need thereof a composition comprising an effective amount of a polyphenolic compound selected from tannic acid, ellagic acid, and combinations thereof, and a peptide having the sequence Val-Gly-Val-Ala-Pro-Gly (SEQ ID NO: 19), wherein the effective amount of the polyphenolic compound ranges from about 1 microgram to about 10 micrograms.

7. The method of claim 6 , further comprising administering a stimulator of elastogenesis selected from elastin-derived peptides, plant-derived peptides, bovine-derived peptides, manganese, iron, copper, and any combination thereof.

8. The method of claim 7 , wherein the composition and the stimulator of elastogenesis are administered simultaneously or sequentially.

9. A method of treating wrinkles and fine lines on skin comprising topically administering to the skin a composition comprising an effective amount of a polyphenolic compound selected from tannic acid, ellagic acid, and combinations thereof, and a peptide having the sequence Val-Gly-Val-Ala-Pro-Gly (SEQ ID NO: 19), wherein the effective amount of the polyphenolic compound ranges from about 1 microgram to about 10 micrograms.

10. The method of claim 9 , further comprising administering a stimulator of elastogenesis selected from elastin-derived peptides, plant-derived peptides, bovine-derived peptides, manganese, iron, copper, and any combination thereof.

11. The method of claim 10 , wherein the composition and the stimulator of elastogenesis are administered simultaneously or sequentially.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: ELASTOGENESIS LLC
To: NULASTIN, INC.
Reel/Frame 068190/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: THE HOSPITAL FOR SICK CHILDREN
To: ELASTOGENESIS LLC
Reel/Frame 067829/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: HUMAN MATRIX SCIENCES, LLC
To: ELASTOGENESIS, LLC
Reel/Frame 048891/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2017
From: JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 043756/0687 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2017
From: HINEK, ALEKSANDER
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 043756/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2017
From: MITTS, THOMAS
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 044056/0797 →